ATLANTIC manufactures Calcium Acetate Tablets which are prescribed for hyperphosphatemia for the final stage Renal Failure patient.
Low-Phos (Calcium Acetate), for individualized phosphate binding treatment, is simply easier for patients to swallow. Patients experience no Constipation, and very low incidence of bloating or gas common to calcium carbonate
Low-Phos is less often associated with hypercalcemia and presents no threat of aluminium toxicity and is not known to worsen hypochlorhydria
Compositions Available
Each uncoated tablet contains
Calcium Acetate USP - 667 mg
Packaging
A pack of bottle contains 75 tablets.
Download
Catalogue of Low Phos Tablets
Serve over 50,000 patients per year
Assist in over 5 Million dialysis treatments per year